Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
115 participants
OBSERVATIONAL
2020-04-20
2020-07-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gut Microbiota Profile and Its Impact on Immunity Status in COVID-19 Vaccinated Cohorts
NCT04980560
Studies of the Human Microbiome in Clinical Center Patients
NCT01933620
A Controlled Study on Regulation of Systemic Inflammation by Fecal Bacteria Transplantation in Patients With COVID-19.
NCT05873348
A Study to Explore the Role of Gut Flora in COVID-19 Infection
NCT04359836
Evaluation of Gut Microbiota and Its Associated Resistome in FMT Donors and Recipients Due to Recurrent Clostridiodes Difficile Infection
NCT06533800
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ambulatory
Patients that are self-isolated at home
Exposure
Individuals with SARS-CoV-2 exposure and COVID-19 symptoms.
Ward
Patients that are in an isolated room at the hospital
Exposure
Individuals with SARS-CoV-2 exposure and COVID-19 symptoms.
ICU
Patients that are in the ICU of the hospital
Exposure
Individuals with SARS-CoV-2 exposure and COVID-19 symptoms.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exposure
Individuals with SARS-CoV-2 exposure and COVID-19 symptoms.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* COVID-19 patients.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital de São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental
UNKNOWN
Centro Hospitalar Universitário São João
UNKNOWN
CUF Academic and Research Medical Center
UNKNOWN
Hospital CUF Infante Santo, S.A.
UNKNOWN
Centro de Medicina Laboratorial Germano de Sousa, S.A.
UNKNOWN
CINTESIS - Center for Health Technology and Services Research
UNKNOWN
Universidade Nova de Lisboa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Conceição Calhau, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidade Nova de Lisboa
Pedro Póvoa, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital São Francisco Xavier
Cristina Granja, PhD
Role: PRINCIPAL_INVESTIGATOR
Centro Hospitalar Universitário São João
Maria JR Sousa, PhD
Role: PRINCIPAL_INVESTIGATOR
Centro de Medicina Laboratorial Germano de Sousa, S.A.
José Leal, PhD
Role: STUDY_CHAIR
Centro de Medicina Laboratorial Germano de Sousa, S.A.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital CUF Infante Santo, S.A.
Lisbon, , Portugal
Hospital de São Francisco Xavier
Lisbon, , Portugal
Centro Hospitalar Universitário São João
Porto, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVID19_Microbiota
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.